Coagulation TestingCoagulation tests help physicians assess the risk of excessive bleeding, diagnosis of blood-related disorders or developing clots or thrombosis. Routine blood coagulation tests performed to assess blood clotting function in patients include prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin time (TT).

Abbott Laboratories, a global healthcare company dedicated to the development of products and technologies across multiple areas of healthcare, recently announced that it has entered into an agreement with Sekisui Medical to offer coagulation testing solutions for laboratories worldwide with Sekisui’s new CP3000 system.

As per the agreement, Abbott will be the exclusive distributor of Sekisui’s CP3000 in the U.S., Europe, and other areas that recognize the CE Mark. The company will also have non-exclusive distribution rights with Sekisui in China, Hong Kong, Japan and Macau.

Jaime Contreras, senior vice president, Commercial Operations, Diagnostics, Abbott, said, “Collaborating with Sekisui broadens our offerings within hematology, providing an important component needed to improve care for people around the world”.

Sales of the CP3000 are expected to begin later this year in Europe, countries that recognize CE Mark, and non-regulated countries, and in 2016 in the United States.

The CP3000 system, with its broad assay menu and rapid result turnaround time, is designed to rapidly meet the workflow needs of laboratories of all sizes while providing high quality, reliable results. Its features include:

  • Small sample volume requirement
  • High-throughput
  • High quality reagents
  • Compact footprint

The system will be used with Abbott’s Accelerator a3600 lab automation platform and middleware solutions.

Abbott Diagnostics is well known for its quality analyzers such as the i-STAT 1 Point Care Analyzer. This FDA-cleared and CLIA-waived portable clinical analyzer delivers lab-accurate testing for blood gases, electrolytes, chemistries, coagulation, hematology, glucose and cardiac markers (cTnI) – with just two drops of blood.